Viemed Healthcare (VMD) Equity Average (2018 - 2026)

Viemed Healthcare (VMD) has 9 years of Equity Average data on file, last reported at $144.7 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 7.13% year-over-year to $144.7 million; the trailing twelve-month figure through Mar 2026 stood at $144.7 million (up 7.13% YoY), and the FY2025 full-year result was $138.4 million, up 11.98% from the prior year.
• Equity Average for Q1 2026 stood at $144.7 million, up from $139.5 million in the prior quarter.
• Across five years, Equity Average topped out at $144.7 million in Q1 2026 and bottomed at $93.6 million in Q3 2022.
• The 5-year median for Equity Average is $115.1 million (2024), against an average of $116.6 million.
• The widest annual swing landed in 2023, when Equity Average advanced 3.29%; it then climbed 17.33% in 2025.
• A 5-year view of Equity Average shows it stood at $95.5 million in 2022, then climbed by 16.6% to $111.4 million in 2023, then grew by 16.79% to $130.0 million in 2024, then gained by 7.27% to $139.5 million in 2025, then advanced by 3.69% to $144.7 million in 2026.
• The last three Equity Average figures came in at $144.7 million (Q1 2026), $139.5 million (Q4 2025), and $138.6 million (Q3 2025), per Business Quant data.

Peer Comparison